- 中国精品科技期刊
- 中国高校百佳科技期刊
- 中国中文核心期刊
- 中国科学引文数据库核心期刊
| Citation: |
ZHANG Shengmiao, SUN Haopeng, JIA Jianmin, XU Xiaoli, YOU Qidong. Advances on indenoisoquinoline compounds with antitumor activities[J]. Journal of China Pharmaceutical University, 2013, 44(6): 589-595. DOI: 10.11665/j.issn.1000-5048.20130620
|
| [1] |
Pommier Y,Cushman M.The indenoisoquinoline noncamptothecin topoisomerase I inhibitors:update and perspectives[J].Mol Cancer Ther,2009,8(5):1 008-1 014.
|
| [2] |
Tomicic MT,Kaina B.Topoisomerase degradation,DSB repair,p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors[J].Biochim Biophys Acta,2013,1 835(1):11-27.
|
| [3] |
Sun Y,Wang HP,Zhou Y,et al.Recent advances in non-camptothecin DNA topoisomerase I inhibitors as anticancer drugs[J].Prog Pharm Sci(药学进展),2011,35(9):385-395.
|
| [4] |
Sedelnikova OA,Redon CE,Dickey JS,et al.Role of oxidatively induced DNA lesions in human pathogenesis[J].Mutat Res,2010,704(1/2/3):152-159.
|
| [5] |
Kinders RJ,Hollingshead M,Lawrence S,et al.Development of a validated immunofluorescence assay for gammaH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity[J].Clin Cancer Res,2010,16(22):5 447-5 457.
|
| [6] |
Pommier Y.DNA topoisomerase I inhibitors:chemistry,biology,and interfacial inhibition[J].Chem Rev,2009,109(7):2 894-2 902.
|
| [7] |
Sheng C,Miao Z,Zhang W.New strategies in the discovery of novel non-camptothecin topoisomerase I inhibitors[J].Curr Med Chem,2011,18(28):4 389-4 409.
|
| [8] |
Nagarajan M,Morrell A,Fort BC,et al.Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings[J].J Med Chem,2004,47(23):5 651-5 661.
|
| [9] |
Morrell A,Placzek M,Parmley S,et al.Nitrated indenoisoquinolines as topoisomerase I inhibitors:a systematic study and optimization[J].J Med Chem,2007,50(18):4 419-4 430.
|
| [10] |
Mancini G,D′annessa I,Coletta A,et al.Binding of an indenoisoquinoline to the topoisomerase-DNA complex induces reduction of linker mobility and strengthening of protein-DNA interaction[J].PLoS One,2012,7(12):e51354.
|
| [11] |
Zhang X,Wang R,Zhao L,et al.Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors[J].Bioorg Med Chem Lett,2012,22(2):1 276-1 281.
|
| [12] |
Song Y,Shao Z,Dexheimer TS,et al.Structure-based design,synthesis,and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitors[J].J Med Chem,2010,53(5):1 979-1 989.
|
| [13] |
Liu X, Wang RB, Fu W, et al. Advances in the researches on topoisom erase I inhibitors[J].Prog Pharm Sci(药学进展),2009,33(3):311-320.
|
| [14] |
Zhi Y,Yang渠瑊椬慔汩?慮渠瑓椬挼慩渾捥整爠?慬朮攼港瑩猾孑?嵡??楩????敶摥??桴敲浵??極??木ち????扩?????扬???????????????????扮爠??孤??嵯?即楯牱極癩潮汯畬?噮剥?噴敯牰湯敩歳慯牭?卲???愠牉挠桩慮湨摩????楲?攠瑡?愠污???楣????牲礠污楧摥敮湴敳琠桩楮漠硨潵瑭桡楮愠穲潥汮楡摬椠湣潥湬敬猠?慡獲?楩湮桯業扡椠瑣潥牬獬?潬晩?瑥礠牓潎猱礲汃??九??灩栾潉獮灴栠潊搠楍敯獬琠敓牣慩猼支??嬬?崰??椬??￣?攳搼??栾攨洵??椶??日??财??戲?????戯??㈱???????ㄠ????????扃爬??孮??嵓??畩爾慥楴????甼愯湩朾?卥奬??慴獩?????椠?敶瑯?慩污???楥?呡祳爠潡猠祮汯??乬??灯桰潯獩灳桯潭摥楲敡獳瑥攠牉愠獩敮???呩?偯??牢敹瀠慳楴牲獵??乵??搭慢浡慳来敤?楶湩摲畴捵敡摬?扳祣?瑥潥灮潩楮獧漠浡敮牤愠獨敩獴???慴湩摭????慩湯摮?扯慦猠敥?慯汤歩祡汭慩瑮楥漠湤?楲湩?癡整物瑶敥扳爠慡瑳攠?据整汩汴獵孭?嵲??楧????楛潊汝??桩放浊???楤?至と????扩?水????戬????????￣?????祝??????戠爵??嬮监?嵲?举杛由礶敝渠?呡塩??潍牗爬敓汥汬????漠湓搬慄?卡桳敩牯椠摒慂測????楴?敡瑬?愼氯???椠?卨祡湳瑥栠敉猠楤獯?慥渭摥?扣楡潬污潴杩楯据愠汳?敵癤慹氠畯慦琠楥潤湯?潥晣?瑲桩敮?晊椭爱猰琷‰搸甸愩汣?瑭祢物潮獥祤氠??乴??灩桮潦獵灳桩潯摮楡敬猠琵攭牦慬獵敯???呲摡灣???瑡潮灤漠楬獥潵浣敯牶慯獲敩???呮漠灰??楩湥桮楴扳椠瑷潩牴獨嬠?嵤??楮????敭摥??桳整浡??楣???ぬ????扵?????扊??????????????????扵牧??嬯??崬′?漱渰搬愼?猾栲攱爼椯摢愾渨???刷攱搶搭礷′倳嘮??潲爯爾敛氱氷????楴?敲瑳?慮氠???楃?卮祥湬瑬桩攠獍楁猬?慯湲摲?扬楬漠汁潅本椼捩愾汥?攠癡慬氮甼愯瑩椾潁湬?潯晨?楬渭搬敤湩潯楬猭漬煡畮楤渠潣污楲湢敯獨?瑤桲慡瑴?椠渭桳極扢楳瑴?扴潵瑴桥?琠祩牮潤獥祮汯??乯??灩桮潯獬灩桮潥摳椠敡獳琠整牯慰獯敩???呥摲灡??愠湉搠?瑮潨灩潢楩獴潯浲敳爺慩獮敶???呩潧灡??孮?崠??楥????敡摴??桮敳浨??楳???ぶ????扮?????扲??????????べ???扤牲??孥??嵢??慤睩獮潧測????塢楩慯?婯?呩档敡?爠敡瑣楴湩潶楩摴?塛?牝攮挼敩瀾瑊漠牍獥?愠湃摨?瑭格支楩爾?氲椰朱愱測搼獢嬾?崴??楢??椱漴挩栺椴洠??椷漭瀴栠礹猵″?挼瑢慲??楛????????戠????????戠????????????扨牥??孳㈠?嵮?倠慡牮歴?????潣湥摲攠牡慣瑴祩當歩?呩健??潯牦爠收氭污????楮?敥瑮?慩汳???楩??湬摩畮捥瑳楛潊湝?漼晩￣牃敨瑩楮渠潊椠摍?塤?牃敨捥敭瀼琯潩爾?愭揽瑯楩瘖楦瑂秗?愬渲搰?挲漬渼獢放焲甲攼港瑢￣用瀴爩攺朲甶永愭琲椷漵渮?潢晲?瀾??圹??????偹??扵祭?楲渠摄攬湄潥楸獨潥煩畭楥湲漠汔楓測敔獥?楣湨??????挼敩氾汥獴嬠?嵬??椯??慍湯捬敥牣?偬牡敲瘠?剮敤猠?健桬楬汵慬???楰???ね????扯????扦??????????????扣牡??孴?ぴ嵨??潩湮搠慴?印桯敩牳楯摭慥湲???倠慉爠歩?????整捯歲?????椭?攴琴′愸氲???椮??放獍楯杬渠?獡祮湣瑥桲攠獔楨獥?愼港摩￣戬椲漰氱漱本椼换愾氱‰攼瘯慢氾用愸琩椺漱渠?漹昰?椱渠搴改渹漮椼獢潲焯甾楛渲漰汝椠湐敯?牭敩硥楲渠潙椮摄獲?睧楧瑩桮?挠桴敯浰潯灩牳敯癭敥湲瑡楳癥敳?灬潥瑳敳湯瑮楳愠污孮?崠??楡????敧摥??桊敝洮??椾?????????????水?????日??????戸爼??嬾??崩??漲甭欹栵愮爼獢歲礯愾???噝攠牋捵桲牴慺敢来敲湧???听潒灯潴楨猠潓洬敋牲慵獭敢???楺渠桒椬戼楩琾潥牴猠?慬渮搼?捩愾湇捥敮牺?琶栴攴爲愸瀲礬孡?嵮??楥??敮浯慮琭潣污?佰湴捯潴汨??汩楮渠?乯潰牯瑩桳??浥??楳????????扢?????扦??????っ???????扴牭??孴??嵝?刼慩社??桩慮甠摃桡畮牣楥????慳猼栯楩派漬琲漰?失??敢爾爱愷搼漯牢￣刨??椺?攠琷?愷氭???椸?吮漼灢潲椯猾潛洲攲牝愠獚敨???瀠潓椬獌潩湵椠湘本?牡敷獡甭汫瑨獡?楦湥?偔?刼偩?浥整搠楡慬琮攼搯?爾敉灤汥楮捴慩瑦楩潣湡?晩潯牮欠?牦攠癴敨牥猠慭汯孬?嵣??楡?丠慢瑡?卩瑳爠畯捦琠??潸汯??楢潩汣??椭???ふ????扣?????扴??????????金??>Nat Med,2012,18(11):1 639-1 642.
|
| [15] |
Kiselev E,Deguire S,Morrell A,et al.7-Azaindenoisoquinolines as topoisomerase I inhibitors and pote
|
| [1] | YANG Qian, WANG Xiaojian. Research progress of sphingosine kinase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2021, 52(6): 759-768. DOI: 10.11665/j.issn.1000-5048.20210615 |
| [2] | LI Yin, GU Hongfeng, ZOU Yi, WANG Shuping, XU Yungen. Research progress of mono-(ADP-ribosyl) transferase family and their inhibitors in tumor therapy[J]. Journal of China Pharmaceutical University, 2021, 52(6): 643-652. DOI: 10.11665/j.issn.1000-5048.20210601 |
| [3] | BU Hong, ZHOU Jinpei, ZHANG Huibin. Research progress of mitogen-activated protein kinase interacting kinases inhibitors in tumor immunotherapy[J]. Journal of China Pharmaceutical University, 2021, 52(4): 410-421. DOI: 10.11665/j.issn.1000-5048.20210403 |
| [4] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
| [5] | TIAN Jiping, ZHANG Jian, ZHOU Jinpei, ZHANG Huibin. Advances in small molecule inhibitors of PD-1/PD-L1 immune checkpoint pathway[J]. Journal of China Pharmaceutical University, 2019, 50(1): 1-10. DOI: 10.11665/j.issn.1000-5048.20190101 |
| [6] | LIU Kejun, ZHANG Zhimin, RAN Ting, CHEN Hongli, LU Tao, CHEN Yadong. Advances in BET bromodomain protein inhibitors[J]. Journal of China Pharmaceutical University, 2015, 46(3): 264-271. DOI: 10.11665/j.issn.1000-5048.20150302 |
| [7] | ZHANG Yuan, CHENG Yulan, ZHOU Jinpei, ZHANG Huibin. Advances on receptor tyrosine kinase inhibitors taking c-Met as anti-tumor target[J]. Journal of China Pharmaceutical University, 2015, 46(1): 16-27. DOI: 10.11665/j.issn.1000-5048.20150102 |
| [8] | LI Chunhong, DU Hongjin, WEN Xiao′an, SUN Hongbin. Advances in inhibitors of MDM2 and MDM4[J]. Journal of China Pharmaceutical University, 2015, 46(1): 1-15. DOI: 10.11665/j.issn.1000-5048.20150101 |
| [9] | DENG Lian-bai, LI Ai-xiu, JIN Yu-rui. Advances in the study on inhibitors of RNase H,a novel anti-HIV drug target[J]. Journal of China Pharmaceutical University, 2011, 42(6): 578-584. |
| [10] | KONG Kai-lai, LU Shuai, GAO Yi-ping, YANG Pei, TANG Wei-fang, LU Tao. Advances on the study of PLK1 inhibitors as antitumor agents[J]. Journal of China Pharmaceutical University, 2011, 42(1): 9-15. |
| 1. |
郁莉，蒋颖敏，许磊，朱景宇. 分子对接与分子动力学模拟法探究PI3Kδ/度维利塞(Duvelisib)的选择性结合. 化学研究与应用. 2022(02): 341-348 .
| |
| 2. |
蔡燕飞，陈蕴，史劲松，金坚. 抗肿瘤药物体外药效学评价结合细胞生物学实验教学促进教研融合. 实验室研究与探索. 2020(08): 192-195 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Total visits：285535
DownLoad: